VA
Vaishali Pharma Ltd (VAISHALI)
₹8.38
Mkt cap
₹115 Cr
P/E ratio
27.00
P/B
1.58
Div yield
0.00%
ROE
6.02%
ROCE
8.90%
EPS (TTM)
₹0.31
Book value
₹5
52W range
5–12
Sector
Healthcare
Price history
Previous close
Incorporated in 1989, Vaishali Pharma Ltd does marketing of pharmaceutical products including active pharmaceutical ingredients [1]
NSE VAISHALI
Health check
Mixed
ValuationCheap
ProfitabilityWeak
GrowthLow
TechnicalsBullish
52-week range
−31.31% from high₹8
₹5+76.42% from low₹12
Current
₹8.38
Prev close
₹8.35
Day
+0.36%
Price performance
1D
+0.36%
1W
−1.76%
1M
+4.36%
3M
+14.64%
6M
+71.72%
1Y
−30.11%
YTD
−4.12%
Financials
Revenue, profit & margin
P/E ratio
27.0×
VAISHALI is 22% below the sector median of 34.6×
VAISHALI27.0×
Sector median34.6×
| Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Trend | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 13.42 | 12.57 | 27.90 | 32.40 | 18.08 | 20.79 | 27.91 | 32.25 | 23.75 | 33.45 | 24.65 | 26.93 | 22.89 | |
| Expenses | 11.11 | 9.92 | 24.95 | 39.19 | 15.73 | 18.37 | 26.55 | 38.29 | 22.38 | 32.06 | 23.09 | 27.13 | 21.40 | |
| Operating Profit | 2.31 | 2.65 | 2.95 | -6.79 | 2.35 | 2.42 | 1.36 | -6.04 | 1.37 | 1.39 | 1.56 | -0.20 | 1.49 | |
| OPM % | 17.21% | 21.08% | 10.57% | -20.96% | 13.00% | 11.64% | 4.87% | -18.73% | 5.77% | 4.16% | 6.33% | -0.74% | 6.51% | |
| Other Income | 0.36 | 0.30 | 0.47 | 0.91 | 0.42 | 0.71 | 1.07 | 1.00 | 0.84 | 0.84 | 0.89 | 1.26 | 0.58 | |
| Interest | 0.43 | 0.47 | 0.43 | 0.40 | 0.38 | 0.38 | 0.38 | 0.44 | 0.33 | 0.40 | 0.51 | 0.72 | 0.20 | |
| Depreciation | 0.12 | 0.12 | 0.12 | 0.14 | 0.12 | 0.12 | 0.12 | 0.12 | 0.14 | 0.17 | 0.13 | 0.16 | 0.14 | |
| Profit before tax | 2.12 | 2.36 | 2.87 | -6.42 | 2.27 | 2.63 | 1.93 | -5.60 | 1.74 | 1.66 | 1.81 | 0.18 | 1.73 | |
| Tax % | 25.00% | 27.97% | 26.13% | -26.95% | 25.11% | 25.10% | 24.87% | -23.39% | 26.44% | 28.31% | 28.18% | -50.00% | 13.87% | |
| Net Profit | 1.59 | 1.70 | 2.11 | -4.68 | 1.70 | 1.97 | 1.44 | -4.29 | 1.28 | 1.18 | 1.30 | 0.27 | 1.49 | |
| EPS in Rs | 0.15 | 0.16 | 0.20 | -0.44 | 0.16 | 0.18 | 0.13 | -0.40 | 0.12 | 0.09 | 0.10 | 0.02 | 0.11 | |
| Raw PDF |
Earnings
Results dates & reactionsNo upcoming results date on calendar.
Fresh quarters land in the Financials table above, tagged NSE until screener catches up.
Avg earnings-day move −2.00% · closed higher next day 0 of last 1
| Q1FY27 | |
|---|---|
| Broadcast | 14 Aug '26◦ |
| Earnings day | −2.00% |
| +1 day | −1.18% |
| +5 days | −4.58% |
| +15 days | −1.65% |
| +30 days | −1.41% |
| Filing |
Corporate actions
Last 6 monthsNo recent corporate actions
Dividends, splits, and bonuses in the last six months show up here.
Shareholding
as of Jul 202630.54%Promoter
Promoters30.54%1.07
Public69.46%1.07
Ownership trend
Peers
8 companiesValuation vs quality
P/E × ROCE · bubble = market cap| Name | CMP | P/E | Mkt Cap | Div Yld | NP Qtr | Qtr Profit Var | Sales Qtr | Qtr Sales Var | ROCE |
|---|---|---|---|---|---|---|---|---|---|
| Sun Pharma.Inds. | ₹1,837.30 | 34.90 | 4,40,830 | 0.87% | 2,901 | +5.95% | 15,300 | +10.46% | 20.53% |
| Divi's Lab. | ₹9,375.00 | 83.54 | 2,48,877 | 0.32% | 902 | +65.50% | 3,080 | +27.80% | 21.97% |
| Torrent Pharma. | ₹4,840.00 | 82.51 | 1,84,098 | 0.79% | 566 | +5.79% | 4,921 | +54.85% | 15.19% |
| Zydus Lifesci. | ₹1,160.00 | 23.77 | 1,15,710 | 0.09% | 990 | −35.09% | 8,017 | +21.96% | 21.14% |
| Cipla | ₹1,394.50 | 31.48 | 1,12,656 | 0.93% | 786 | −39.19% | 7,119 | +2.33% | 15.49% |
| Laurus Labs | ₹1,954.00 | 96.56 | 1,05,577 | 0.10% | 362 | +125.49% | 2,026 | +29.10% | 17.76% |
| Aurobindo Pharma | ₹1,734.00 | 26.39 | 99,771 | 0.23% | 1,032 | +28.11% | 9,150 | +16.30% | 12.86% |
| Vaishali Pharma | ₹8.79 | 27.05 | 115 | 0.00% | 1 | +16.41% | 23 | −3.62% | 8.90% |
| Median: 158 Co. | ₹433.90 | 34.56 | 2,205 | 0.08% | 13 | +29.57% | 164 | +18.57% | 14.96% |
Filings
Annual reports7
Concall transcripts6
Announcements5
General Updates 4 Sep - NSE approved listing of 45,37,865 preferential equity shares, pending depository confirmation.Copy of Newspaper Publication 3 Sep - Company published newspaper advertisements for its 19th AGM in English and Marathi editions.General Updates 1 Sep - Book closure from 18-24 Sep 2026; record date 17 Sep 2026 for 19th AGM e-voting.Record Date 1 Sep - Book closure 18-24 Sep 2026; record date 17 Sep 2026 for Vaishali Pharma's 19th AGM.Shareholders meeting 1 Sep - 19th AGM on 24 Sept 2026 via VC/OAVM; book closure 18-24 Sept, Jagruti Vasani up for reappointment.